Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Momenta Pharmace Has Returned 7.6% Since SmarTrend Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on March 26th, 2020 at $28.54. In approximately 2 months, Momenta Pharmace has returned 7.64% as of today's recent price of $30.72.

MNTA : 32.48 (-0.34%)
Momenta: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $39.6 million in its first quarter.

MNTA : 32.48 (-0.34%)
Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results

-- Top-line interim data from nipocalimab Vivacity-MG study expected by Q3 2020 --

MNTA : 32.48 (-0.34%)
Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and Webcast

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 32.48 (-0.34%)
10.5% Return Seen to Date on SmarTrend Momenta Pharmace Call (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on March 26th, 2020 at $28.54. In approximately 4 weeks, Momenta Pharmace has returned 10.51% as of today's recent price of $31.54.

MNTA : 32.48 (-0.34%)
Momenta Pharmace Rises 4.36% on Heavy Volume: Watch For Potential Pullback

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $28.63 to a high of $34.63. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high...

MNTA : 32.48 (-0.34%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Myriad Genetics (MYGN , FLXN , MNTA , XBIT , CCXI )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

FLXN : 11.70 (+13.26%)
MNTA : 32.48 (-0.34%)
MYGN : 14.69 (+0.69%)
Momenta Provides Corporate Update Amid COVID-19 Pandemic

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today provided an update...

MNTA : 32.48 (-0.34%)
Momenta (MNTA) Down 0.3% Since Last Earnings Report: Can It Rebound?

Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MNTA : 32.48 (-0.34%)
Shares of Emergent Biosolu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (EBS , MNTA , EGRX , CVM, BIIB )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

EGRX : 52.53 (-1.65%)
EBS : 83.64 (-0.58%)
MNTA : 32.48 (-0.34%)
Watch for Momenta Pharmace to Potentially Pullback After Gaining 1.58% Yesterday

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $31.17 to a high of $32.87. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

MNTA : 32.48 (-0.34%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (GILD , MNTA , BIIB , INCY , REGN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BIIB : 304.02 (+0.85%)
GILD : 75.77 (+1.16%)
MNTA : 32.48 (-0.34%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 123.07 (-0.54%)
MNTA : 32.48 (-0.34%)
LHCG : 161.04 (-0.89%)
NEOG : 71.36 (-1.92%)
XLV : 102.64 (+2.16%)
VHT : 196.12 (+2.07%)
Momenta's (MNTA) Q4 Loss Wider than Expected, Sales Beat

Momenta (MNTA) reports mixed Q4 results, with a wider-than-expected loss and revenues beating the same.

TEVA : 13.02 (+0.85%)
REGN : 574.60 (+5.62%)
MYL : 17.38 (+1.28%)
MNTA : 32.48 (-0.34%)
Momenta Pharmaceuticals (MNTA) Reports Q4 Loss, Tops Revenue Estimates

Momenta (MNTA) delivered earnings and revenue surprises of -49.12% and 64.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

MNTA : 32.48 (-0.34%)
Momenta: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Wednesday reported a loss of $86.7 million in its fourth quarter.

MNTA : 32.48 (-0.34%)
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

-- Reported favorable interim data from Phase 1/2 study of M254 in ITP, supporting expansion of Part B; expect to report updated data in Q2 2020 and launch additional Phase 2 study in CIDP in Q4 2020 --...

MNTA : 32.48 (-0.34%)
Momenta Pharmaceuticals to Webcast Presentation at the Cowen 40th Annual Health Care Conference

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 32.48 (-0.34%)
Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks

The small-cap healthcare companies are benefiting from the 2020 presidential election campaign, which has put pressure on the large cap cousins on how to overhaul the industry.

ENDP : 4.07 (+3.56%)
OMI : 7.86 (+1.81%)
CYH : 3.31 (-5.16%)
MNTA : 32.48 (-0.34%)
CYTK : 21.05 (-0.89%)
PSCH : 123.07 (-0.54%)
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2019 Financial Results Conference Call and Webcast

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 32.48 (-0.34%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -1.11 , SEDG +0.25 , THC -0.31 , TER -0.96 , LITE +0.13
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar